EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.628
https://www.valueinhealthjournal.com/article/S1098-3015(22)02832-7/fulltext
Title :
EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02832-7&doi=10.1016/j.jval.2022.09.628
First page :
Section Title :
Open access? :
No
Section Order :
10165